encorafenib,Binimetinib,Cetuximab
pfizer,ono pharmacueticals,pierre fabre,eli lilly
[]
 an entirely unecessary single arm study. this should have been randomised to compare against chemo. a waste of patients and their potential.
Junior Doctor at Southampton. Tweets my own. No FCOI.